Underutilization of germline BRCA testing in commercially-insured women diagnosed with ovarian cancer.

5539Background: Germline BRCA (gBRCA) testing has prognostic, therapeutic, and familial implications for patients with ovarian cancer. Since 2010, national guidelines have recommended universal gen...